Log inTry free

Relay Therapeutics (RLAY) stock

Market cap $4.1B

$19.39
+2.27%

Market closed. Prices as of Monday's close.

Quality Score
9
Average
In its industry
#43of 300
Biotech

RLAY's Quality Score rose 2 points on Mon, Oct 5, to 9. Came within 10% of its 52-week high. 1 more reason, for Pro members.

NextEarly 2027“…for 1L breast cancer; Phase 3 1L trial in endocrine-sensitive patients expected to initiate in early 2027…”Trial start · 8-K, Aug 6

Follow RLAY's trial news. Pro members can get an alert when Relay Therapeutics files news, and see its trials, share raises, and its CEO's filings.

Get an optional alert when RLAY files news on its trialsSee it live, free until tomorrow morning. No account. No card. Then keep going with a free account.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

What's next for RLAY, and how long its cash lasts

From Relay Therapeutics’s SEC filings and ClinicalTrials.gov: the company’s own words, the registry’s dates, and arithmetic, not a forecast. Companies often miss their own dates.

Next step the company has named

Early 2027“…plus atirmociclib as go-forward triplet regimen for 1L breast cancer; Phase 3 1L trial in endocrine-sensitive patients expected to initiate in early 2027, subject to regulatory feedback”Trial start · 8-K, Aug 6

What it means: when a trial begins, or reaches the stage the company named.

Lead program
Atirmociclib
Another trial
ReDiscover-2Phase 3 · Recruiting · 540 people · main data estimated Apr 30, 2028 · NCT06982521

3 more trials, 31 filings, for Pro members.

Cash runway

The company says its cash lasts into 2029 (8-K, Aug 6).

That is the company's own estimate. Our arithmetic on its latest balance sheet reads differently, so we show its words, not ours.

For Pro members: the cash on hand, the cash used each quarter, and the math.

Dilution on the horizon

No shelf registration of its own or at-the-market program on file in the last three years.

A shelf lets a company sell shares later; an at-the-market program sells them into the market over time. Neither is a sale by itself.

For Pro members: 2 raises and their amounts, and the share count against a year ago.

Insiders

President, R&D Donald A Bergstrom sold 8,530 shares on Sep 8, under a planned sale. 24 more insider trades this year.

From their own Form 4 filings: buys and sales in the market, not awards or shares withheld for tax.

Get an optional alert when Sanjiv Patel buys or sells

For Pro members: every trade, and Sanjiv Patel’s 17 filings and quotes.

Get an optional alert when RLAY files news on its trialsSee it live, free until tomorrow morning. No account. No card. Then keep going with a free account.

See every upcoming FDA date →

FDA dates in the next 60 days

Decision dates and advisory committee meetings the companies have announced in their own filings, soonest first and small companies first.

DateStockDrug

8 more FDA dates and 113 trial data dates in the next 60 days. Pro members see every one, with the cash against its date and an optional alert before it. Get in free →

Why RLAY beats the market

Relay Therapeutics returned +247% over the past year to the S&P 500's +17%; diluted EPS went from -$2.36 to -$1.61.

Sources: Price history, Oct 5, 2026; Annual reports, Dec 31, 2025

2 drivers, the timeline, and the peer table, for Pro members

Why RLAY scores 9

AverageChoppy, 5 of 14 checks firingWhat the Quality Score means

Poor is below 0. Average starts at 6, Above Average at 11, Excellent at 15, and Exceptional at 20.

  • +5Chart checks 5 of 14 firing right now, one point each
  • +3Long-term trend above a rising 200-⁠day average, near its 52-⁠week high
  • Run-up adds
  • Profit subtractsRead on the last four quarters against the four before, or the last full year where no quarters are filed.
  • Growth addsSales and margins against a year earlier: up to +3 for fast growth and widening margins, down to -2 when both shrink.
  • Dilution subtractsNew shares over the year: -1 at 10% more, -2 at 25% more.
  • Cash flow subtracts-1 when free cash flow over the last four quarters is negative.

No effect today: Size, Volatility, Persistence, News, and Insider trades.

What every line is worth, and the reason behind it, on RLAY and every other stock.Get in free →

Price, score, chart checks, and the industry rank are from a snapshot taken at 2:09 AM ET, at least 15 minutes behind. How we rank stocks.

What's next

Expected to report Thu Nov 5, after the close

After its last 4 reports it closed +1.0% on average, higher 2 of 4 times.

What would move RLAY's score: 7 things, for Pro members

Alert me when RLAY's Quality Score turns up

See it live, free until tomorrow morning. No account. No card. Then keep going with a free account.

Here is what Pro members see.

  • The same page for Pro members, on AMD

    Its Quality Score and rank, the line that drives it, and the live price with the bid and ask.

  • The full chart

    A year of candles to start, out to the whole history, with insider trades marked and the Quality Score under the price.

  • Every line of the score

    Price action, the company, and signals, each with its points, on RLAY and every other stock.

  • FDA dates, counted down

    Each date in the company's own words, its cash against the date, and an optional alert before it.

  • Why a stock ranks

    Its Quality Score, its rank, and the reasons behind it, on one card.

  • CEOs buying their own stock

    Every CEO buy, biggest names first. Sort, filter, download a CSV, and set optional alerts.

  • Congress trades

    Each member's trades. Sort, filter, download a CSV, and set optional alerts.

  • All 14 chart checks

    Trend, volume, tight range, and buying, each lit when it fires, its rule a tap away.

  • Earnings, week by week

    Who reports each day, and how each stock took its last four reports. Optional alerts before them.

  • The market map

    Every stock a box, colored by its Quality Score.

  • Themes, ranked live

    AI chips, quantum, nuclear, defense, space, and more, each stock ranked by its Quality Score.

  • The top 10, every day

    The ten highest Quality Scores at each close, kept day by day, week by week.

  • Optional alerts, your way

    Pick a stock, a score, a price, a filing, or a whole scan. It tells you by push, email, or the bell.

  • Your watchlist, scored

    Your stocks by Quality Score, today's move, or name, with optional alerts.

  • A trade plan, from the chart

    Entry, stop, and two targets on every stock's page. Type your risk and it sizes the trade.

  • On your phone and your laptop

    The same account and watchlist on both, each laid out for its screen.

  • Prices refresh every 2.5 seconds during market hours.
  • Optional alerts by push, email, or the bell.
  • Add it to your Home Screen and it opens like an app.

RLAY has 5 of 14 checks firing

One per group is shown here.

Trend1 of 5 shown
MA FAN21 EMAW.EMAHH/HL52W HI

Averages stacked in order, price near its high.

Volume1 of 3 shown
VOLVDUU/D VOL

Heavy volume on the run, quiet volume at rest.

Tight range1 of 3 shown
ATR SQZSQUEEZENR7

The daily range is tight against its own recent history.

Buying1 of 3 shown
OBV+CLOSE HISPRING

Closes near the high, and buyers step in on dips.

The other 10 checks on RLAY, and all 14 on every stock.Get in free →

Also on the chart

Not scored

Shown for reference. None of these counts toward the Quality Score: in our tests on 20 years of daily prices, none of them improved it.

  • RSI 1456.2

    Above 50, below 70.

  • MACD (12, 26, 9)Above signal

    Crossed above its signal line 1 session ago.

  • 50-day average$19.11

    The price is 1.5% above it.

  • 200-day average$14.06

    The price is 37.9% above it. The 50-day is above the 200-day, since Sep 12, 2025.

  • ADX 1416.4

    Under 25, with +DI below -DI.

  • Support$18.33

    Swing low from Jul 13, 5.5% below the price.

  • Resistance$19.69

    Swing high from Sep 17, 1.5% above the price.

  • Bollinger Bands (20, 2)Inside

    The bands run from $17.49 to $19.73.

  • Volume0.8x

    Against its 20-day average, for the time of day.

How RLAY ranks in Biotech

RLAY is #43 of 300 by Quality Score. The top three are shown with their scores, and more by name.

More in Biotech, on the Healthcare page

When does RLAY report earnings, and what happens after?

Expected to report Thu Nov 5, after the close (in 30 days). Not yet confirmed by the company.

ReportedGapReaction5 sessions
Aug 6, 2026After close-3.2%+0.1%+0.9%
May 5, 2026After close+0.1%-0.6%-0.5%
Feb 26, 2026After close+5.2%+12.0%+5.2%
Nov 6, 2025After close-5.4%-7.3%-1.2%

The gap is the next open against the close before the report; the reaction is where that session closed. RLAY closed higher after 2 of its last 4. Past behavior, not a forecast.

Report dates and past reactions come from sessions that have already closed, so none of these figures move.

Who is trading RLAY

RLAY insider trades

4 insiders sold $116M across 4 filings in the last 6 months. No open-⁠market buys on record. The newest:

SellSVF Pauling (Cayman) Ltd$116M10% ownerat $19.40 on Aug 25, filed Aug 28
All 4 insider filings on RLAY from the last six months, for Pro members.Get in free →

An insider has two business days to file a Form 4, so the trade is already days old when it becomes public. Shown as filed, with no delay.

About Relay Therapeutics

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.

192 employeesCambridge, MArelaytx.com

Pro members see every line of every stock's score.

  • Real-⁠time prices, no delay
  • Every line of RLAY's score, with the points and the reason
  • All 14 checks on RLAY and on all 3,243 stocks
  • Every stock ranked, with the chart
  • Every filing, and optional alerts on RLAY
BreakawayAug 28SVF Pauling (Cayman) Ltd sold RLAY$116M at $19.40, filed Aug 28

What a filing on RLAY would have sent. Alerts are optional.

See all 14 checks on RLAYSee it live, free until tomorrow morning. No account. No card. Then keep going with a free account.

Straight Answers

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.

Where does the data come from?

Daily bars, quotes, reference data, headlines, and short interest come from Massive, formerly Polygon, a licensed market data vendor. The age of the quotes is shown at the top of every page. Insider trades, notable holders and profits come straight from the SEC. That means Form 4 filings, 13F filings and XBRL financial data on EDGAR. Government filings come from the public STOCK Act and Office of Government Ethics disclosures. The market-wide headlines on the market line also come from the public headline feeds CNBC, MarketWatch and Yahoo Finance publish, shown as the headline, the source and a link to the article. Splits, dividends, and the financial statements on each ticker page come from the vendor's reference data. The 8-K filings on EDGAR are read for the items that move a price. Five years of history is loaded for every stock. So the 200-day and 52-week checks rest on real history. Options flow is not part of the product.

Do I need an account?

Not to start. Tap any green button and you're in, free, with no email and no password. To keep going, create a free account with Google, Apple, or your email. There is no password to make up.

Is this investment advice?

No. It is a screening tool that scores stocks on the chart, the company's own results, and the news and filings. It does not know your situation and it is not a recommendation to buy or sell anything. Please do your own research.

The price, the score, the chart checks and readings, and the industry rank on this page are delayed at least 15 minutes. Filings are shown as filed, because a disclosure is already days or weeks old when it becomes public. Earnings dates and past reactions are settled sessions.